본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Journal of bacteriology and virology : JBV v.34 no.4, 2004년, pp.321 - 329  
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

The Synergistic Effect of LMP1 and IRF7 on the Expression of TAP1 in DG 75 Cell Line

Park, Ho-Sun  
  • 초록

    In this study, the author explored the role of interferon regulatory factor 7 (IRF7) and latent membrane protein 1 (LMP1) on the regulation of antigen presenting molecules in B-lymphoblastoid cell lines. First, the author observed the endogenous expression of IRF7 and LMP1 in paired EBV-positive B-lymphoblastoid cell lines, Sav I and Sav III, which represent EBV type I and type III latency, respectively. The Sav I cell, which does not express LMP1, showed very low levels of endogenous IRF7 in the cytoplasm. However, Sav III cells, which express large amounts of LMP1, contained high levels of endogenous IRF7 in both the cytoplasm and the nucleus. The expression of surface MHC class I antigen was 7.8-fold higher in Sav III compared with Sav I cells when measured by fluorescence activated cell sorter (FACS) analysis. To understand whether IRF7 is involved in regulation of MHC I and TAP1, LMP1 or IRF7 were expressed by cotransfection in DG75 cells. Levels of TAP1 protein were up-regulated by LMP1 and IRF7 alone, and by LMP1 co expression with IRF7, the expression level was highest after co-transfection of LMP1 with IRF7. TAP1 promoter activity was also up-regulated to 2.4, 2.0, 3.2-fold by LMP1, by IRF7, and by LMP1 plus IRF7, respectively. Surface expression of MHC class I antigen was up-regulated by LMP1 alone and LMP1 plus IRF7, but not by IRF7 alone. These results suggest that IRF7 induces the expression of TAP1, but not MHC class I antigen and that LMP1 and IRF7 have additive effects on the expression of TAP1 protein.


  • 주제어

    TAP1 .   IRF7 .   LMP1 .   EBV .   MHC I.  

  • 참고문헌 (45)

    1. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Fruh K: Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 93: 10990-10995, 1996 
    2. Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS: Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 77: 339-349, 1993. 
    3. Nonkwelo C, Ruf IK, Sample J: Interferon-independent and -induced regulation of Epstein-Barr Virus EBNA-1 gene transcription in Burkitt lymphoma. J Viro 71: 6887-6897, 1997 
    4. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR: Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of pep-tide transporters and HLA-class I antigen expression. Eur J Immunol 25:1374-1384, 1995. 
    5. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL: The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779, 1996 
    6. Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JP: Coordinate regulation of the human TAPI and LMP2 genes from a shared bidirectional promoter. J Exp Med 181: 1459-1471, 1995 
    7. Zhang L, Pagano JS: IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Cell BioI 17: 5748-5757, 1997 
    8. Zhang L, Pagano JS: Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1. J Virol 75: 341-350, 2001 
    9. Gregory CD, Rowe M, Rickinson AB: Different Epstein- Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71: 1481-1495, 1990 
    10. Ning SB, Hahn AM, Huye L, Pagano JS: Interferon Regulatory Factor 7 Regulates Expression of EpsteinBarr Virus Latent Membrane Protein 1: A Regulatory Circuit J Virol 77: 9359-9368, 2003 
    11. Nguyen H, Hiscott J, Pitha PM: The growing family of interferon regulatory factors. Cytokine Growth Factor Rev 8: 293-312, 1997 
    12. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337: 320-322, 1991 
    13. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T: Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548, 2000 
    14. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T: Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259: 971-974, 1993 
    15. Min W, Pober JS, Johnson DR: Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN- gamma signaltransduction pathways. Circ Res 83: 815-823, 1998 
    16. Yeow WS, Au WC, Juaug YT, Fields CD, Dent CL, Gewert DR, Pitha PM: Reconstitution of virus-mediated expression of interferon alpha genes in human fibroblast cells by ectopic interferon regulatory factor-7. J BioI Chem 275: 6313-6320, 2000 
    17. Au WC, Moore PA, Lowther W, Juang YT, Pitha PM: Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci USA 92: 11657-11661, 1995 
    18. Coscoy L, Ganem D: Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA 97: 8051-8056, 2000. 
    19. Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N: Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 67: 6303-6308, 1993 
    20. Rowe DT, Rowe M, Evan GI, Wallace LE, Farrell PJ, Rickinson AB: Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells. EMBO J 5: 2599-2607, 1986 
    21. Sandberg M, Hammerschmidt W, Sugden B: Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J Virol 71: 4649-4656, 1997 
    22. Seliger B, Hammers S, Hohne A, Zeidler R, Knuth A, Gerharz CD, Huber C: IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma. Clin Cancer Res 3: 573-578, 1997 
    23. Gobin SJ, van Zutphen M, Woltman AM, van den Elsen PJ: Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J Immunol 163: 1428-1434, 1999 
    24. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T: Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739, 1989 
    25. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH: A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 18: 1081-1091, 1999 
    26. Rickinson AB, Kieff E: Epstein Barr virus, pp 2599-2612. In Fields Virology, 4th ed. Lippincott William & Wilkins, Philadelphia, 2001 
    27. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G: Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte trans-formation: role in NF-kappaB activation. Mol Cell Biol 16: 7098-7108, 1996. 
    28. Fujita T, Sakakibara J, Sudo Y, Miyamoto M, Ki-mura Y, Taniguchi T: Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO 7: 3397-3405,1988. 
    29. Ishido S, Wang C, Lee BS, Cohen GB, Jung JU: Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74: 5300-5309, 2000 
    30. Marie I, Durbin JE, Levy DE: Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO 17: 6660-6669, 1998 
    31. Stevenson PG, Efstathiou S, Doherty PC, Lehner PJ: Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci USA 97: 8455-8460, 2000 
    32. Kirchhoff S, Schaper F, Hauser H: Interferon regu-latory factor 1 (IRF-1)mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acid Res 21: 2889, 1993. 
    33. Zhang L, Pagano JS: Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. J Virol 74: 1061-1068, 2000 
    34. Ben-Bassat H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, Cohen MM, Bentwich Z, Ramot B, Klein E, Klein G: Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer 19: 27-33, 1977 
    35. Boname JM, de Lima BD, Lehner PJ, Stevenson PG: Viral degradation of the MHC class I peptide loading complex. Immunity 20: 305-317, 2004 
    36. Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL: Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 93:11327-11333, 1996. 
    37. Kieff E, Rickinson AB: Epstein Barr virus and its replication, pp 2519-2541. In Fields Virology, 4th ed. Lippincott William & Wilkins, Philadelphia, 2001 
    38. Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T, Tanaka N, Kamijo R, Vilcek J, Mak TW, Taniguchi T: Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264: 1921-1924, 1994 
    39. Bartee E, Mansouri M, Hovey Nerenberg BT, Gouveia K, Fruh K: Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 78: 1109-1120, 2004 
    40. Au WC, Moore PA, LaFleur DW, Tombal B, Pitha PM: Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem 273: 29210-29271, 1998. 
    41. Johnson DR: Locus-specific constitutive and cytokineinduced HLA class I gene expression. J Immuol 170: 1894-1902, 2003 
    42. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW, Taniguchi: Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839, 1994 
    43. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Thrsz T, Johnson A, Rickinson AB: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69: 1051-1065, 1988 
    44. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B: Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer S42: 329-338, 1988. 
    45. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375: 685-688, 1995 

 저자의 다른 논문

  • Park, Ho-Sun (15)

    1. 1998 "Effects of Hantaan Virus and $IFN-{\gamma}$ on Induction of Surface ICAM-1 in Primary Cultured Human Nasal Epithelial Cells and Human Lung Fibroblasts" 대한바이러스학회지 = The journal of the Korean society of virology 28 (4): 317~325    
    2. 1998 "한탄바이러스의 섬유아세포 감염에 대한 Integrin 항체의 억제 효과" 영남의대 학술지 = Yeungnam University journal of medicine 15 (1): 55~66    
    3. 1998 "분리 세포의 단층세포 배양법에 의한 인체 비점막 상피세포의 배양" 영남의대 학술지 = Yeungnam University journal of medicine 15 (2): 286~296    
    4. 2002 "Sequence-specific Recombinase FLP/FRT를 이용한 항산균 유전자 Knock-out System의 개발 및 Rhamnose 생합성 유전자 rmlD 결손 변이주 제작에의 응용" Journal of bacteriology and virology : JBV 32 (3): 221~230    
    5. 2002 "Fibronectin과 Matrix Metalloproteinase-3에 대한 한탄바이러스의 영향" Journal of bacteriology and virology : JBV 32 (2): 195~201    
    6. 2002 "Effect of Interleukin-10 on Lipopolysaccahride/Interferon-γ-Induced Chemokine Mig Gene Expression" Immune network : official journal of the Korean association of immunobiologists 2 (1): 12~18  
    7. 2003 "THP-1 세포주에서 Leptin에 의한 케모카인 유전자 발현" 영남의대 학술지 = Yeungnam University journal of medicine 20 (2): 129~141    
    8. 2007 "Hantaan Virus Reduces the yon Willebrand Factor in Human Umbilical Vein Endothelial Cells" Journal of bacteriology and virology : JBV 37 (4): 225~230    
    9. 2008 "한탄바이러스가 혈소판활성인자 수용체 발현 및 혈소판활성인자 분해효소 활성에 미치는 영향" 영남의대 학술지 = Yeungnam University journal of medicine 25 (1): 41~49    
    10. 2015 "Effects of Human Adipose-Derived Stem Cells in Regenerating the Damaged Renal Tubular Epithelial Cells in an Animal Model of Cisplatin-Induced Acute Kidney Injury" Childhood kidney diseases 19 (2): 89~97    

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • NDSL :
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기